Common Contracts
2 similar Employment Agreement contracts by Fusion Pharmaceuticals Inc.
EMPLOYMENT AGREEMENTEmployment Agreement • June 22nd, 2020 • Fusion Pharmaceuticals Inc. • Biological products, (no disgnostic substances) • Ontario
This Employment Agreement (“Agreement”) is made between Fusion Pharmaceuticals Inc. (the “Company”), and John Valliant (the “Executive”) and is effective as of the closing of the first underwritten public offering of the equity securities of the Company pursuant to an effective registration statement under the Securities Act of 1933, as amended (United States) (the “Effective Date”). Except with respect to the Restrictive Covenants Agreement and the Equity Documents (each as defined below), this Agreement supersedes in all respects all prior agreements between the Executive and the Company regarding the subject matter herein, including without limitation the Employment Agreement between the Executive and the Company dated October 12, 2018 (the “Prior Agreement”).
EMPLOYMENT AGREEMENTEmployment Agreement • June 22nd, 2020 • Fusion Pharmaceuticals Inc. • Biological products, (no disgnostic substances) • Ontario
This Employment Agreement (“Agreement”) is made between Fusion Pharmaceuticals Inc. (the “Company”), and Eric Burak (the “Executive”) and is effective as of the closing of the first underwritten public offering of the equity securities of the Company pursuant to an effective registration statement under the Securities Act of 1933, as amended (United States) (the “Effective Date”). Except with respect to the Restrictive Covenants Agreement and the Equity Documents (each as defined below), this Agreement supersedes in all respects all prior agreements between the Executive and the Company regarding the subject matter herein, including without limitation the Employment Agreement between the Executive and the Company dated February 16, 2017 (the “Prior Agreement”).
